drugset
drugset / Trial / NCT03848767

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges

NCT03848767 ↗

Completed 10 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelDevice feasibility

Summary

The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system during meal challenges.

Timeline

Start
2019-02-20
Primary completion
2019-04-01
Completion
2019-04-01

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Lispro Protein / enzyme biologic — Subcutaneous

Indications

type 1 diabetes mellitus